This event has been postponed.

Overview

Industrial biotechnology is undergoing a step change in capability with many new start-ups. However, many of the new start-ups have bemoaned the lack of scale-up capability in the UK, despite a number of initiatives such as CPI Wilton, IBioIC, and BioPilots, with a number of them using overseas capacity. 

This one-day event will examine whether sufficient scale-up capacity exists in the UK for start-up companies. This will be in the context of the experience of a variety of Industrial Biotech companies as they have transitioned from laboratory to pilot plant and on to manufacture.

We’ll be particularly looking at the food, enzyme, fine chemicals, and oral pharmaceuticals portions of the sector (and not the large scale energy sector).

This one-day meeting is open to all and offers a programme of invited talks, exhibits, and an interactive workshops session.